1. Home
  2. TRVI vs OEC Comparison

TRVI vs OEC Comparison

Compare TRVI & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • OEC
  • Stock Information
  • Founded
  • TRVI 2011
  • OEC 1862
  • Country
  • TRVI United States
  • OEC Luxembourg
  • Employees
  • TRVI N/A
  • OEC N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • OEC Major Chemicals
  • Sector
  • TRVI Health Care
  • OEC Industrials
  • Exchange
  • TRVI Nasdaq
  • OEC Nasdaq
  • Market Cap
  • TRVI 629.8M
  • OEC 674.8M
  • IPO Year
  • TRVI 2019
  • OEC 2014
  • Fundamental
  • Price
  • TRVI $5.96
  • OEC $10.09
  • Analyst Decision
  • TRVI Strong Buy
  • OEC Buy
  • Analyst Count
  • TRVI 8
  • OEC 2
  • Target Price
  • TRVI $19.31
  • OEC $13.50
  • AVG Volume (30 Days)
  • TRVI 2.5M
  • OEC 560.8K
  • Earning Date
  • TRVI 08-07-2025
  • OEC 07-31-2025
  • Dividend Yield
  • TRVI N/A
  • OEC 0.83%
  • EPS Growth
  • TRVI N/A
  • OEC N/A
  • EPS
  • TRVI N/A
  • OEC 0.46
  • Revenue
  • TRVI N/A
  • OEC $1,852,300,000.00
  • Revenue This Year
  • TRVI N/A
  • OEC N/A
  • Revenue Next Year
  • TRVI N/A
  • OEC $4.76
  • P/E Ratio
  • TRVI N/A
  • OEC $22.02
  • Revenue Growth
  • TRVI N/A
  • OEC N/A
  • 52 Week Low
  • TRVI $2.36
  • OEC $9.59
  • 52 Week High
  • TRVI $7.48
  • OEC $24.85
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 43.31
  • OEC 35.99
  • Support Level
  • TRVI $6.05
  • OEC $10.44
  • Resistance Level
  • TRVI $6.49
  • OEC $12.10
  • Average True Range (ATR)
  • TRVI 0.53
  • OEC 0.43
  • MACD
  • TRVI -0.05
  • OEC -0.11
  • Stochastic Oscillator
  • TRVI 27.62
  • OEC 3.59

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing and special applications. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: